$ELTP Recent News Former CEO of Elite Pharmaceuticals

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$ELTP Recent News

Former CEO of Elite Pharmaceuticals sells all shares 10:47 a.m. Oct. 28, 2004 - James Comtois
Semel's Yahoo stock sales lead weekly insider trades 4:17 p.m. Oct. 25, 2004 - James Comtois
Elite Pharma says ends Nostrum Pharma merger talks 5:19 p.m. Aug. 6, 2004 - Carla Mozee
Elite Pharmaceuticals settles w/former CEO 12:07 p.m. May 3, 2004 - Maggie McNeil
Elite settles w/former CEO, includes $400,000 payment 1:15 p.m. April 1, 2004 - Maggie McNeil
Elite Pharma to negotiate purchase of Nostrum 2:27 p.m. Aug. 8, 2003 - Chris Kraeuter

InsiderInsights.com Daily Round Up 9/29/14: AGCO, UVSP, OPK, RSG 12:03 a.m. Oct. 1, 2014 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1 2015 Results - Earnings Call Transcript 5:12 p.m. Aug. 18, 2014 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1FY2015 Results - Earnings Call Transcript 5:12 p.m. Aug. 18, 2014 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakimon on Q1FY2015 Results - Earnings Call Transcript 5:12 p.m. Aug. 18, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 4:17 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2014 Results - Earnings Call Transcript 4:25 p.m. July 1, 2014 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 1:57 p.m. June 30, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals' CEO Discusses F3Q2014 Results - Earnings Call Transcript 9:19 p.m. Feb. 18, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 9:08 a.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals: Swinging For The Fences 11:53 a.m. Dec. 18, 2013 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 1:10 p.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
1 Stock to Buy, 1 Stock to Short: Pharmaceuticals 12:01 a.m. May 10, 2013 - InvestorPlace.com
Racket of Their Own 12:01 a.m. Aug. 15, 2006 - The Wall Street Journal Interactive Edition
Bristol Nears Approval on New Drug 12:01 a.m. Sept. 4, 2002 - The Wall Street Journal Interactive Edition
Market Movers Sink in First Half 6:32 p.m. July 1, 2002 - The Wall Street Journal Interactive Edition
Arthritis War Set to Commence 1:37 a.m. Nov. 10, 1998 - The Wall Street Journal Interactive Edition

Elite Pharmaceuticals Announces New Management Appointments 7:16 a.m. Oct. 24, 2014 - GlobeNewswire
Elite Pharmaceuticals Releases Positive Top Line Human Abuse Liability Data for ELI-200, an Opioid Abuse Deterrent Product 7:01 a.m. Sept. 9, 2014 - GlobeNewswire
Elite Pharmaceuticals to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 1:48 p.m. Sept. 3, 2014 - GlobeNewswire
OTC Daily Trading News: Evoq Properties, Inc. MedBox, Inc. LabStyle Innovations Corp, MyEcheck, Inc. Elite Pharmaceuticals, Inc. 11:09 a.m. Aug. 19, 2014 - PR Newswire - PRF
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2015 4:15 p.m. Aug. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on August 18, 2014 7:11 a.m. Aug. 13, 2014 - GlobeNewswire
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for ELI-201 10:32 a.m. July 15, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2014 2:07 p.m. June 30, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host 2014 Fiscal Year End Conference Call on Tuesday, July 1, 2014 10:35 a.m. June 26, 2014 - GlobeNewswire
Elite Pharmaceuticals Enters Into $5 Million Settlement Agreement With Novel Laboratories 11:11 a.m. June 10, 2014 - GlobeNewswire
Elite Pharmaceuticals Begins Human Abuse Liability Studies for ELI-200 8:01 a.m. June 9, 2014 - GlobeNewswire
Elite Pharmaceuticals Announces Results of 2014 Annual Meeting of Shareholders 11:10 a.m. May 23, 2014 - GlobeNewswire
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Third Opioid Abuse Deterrent Product 8:16 a.m. May 19, 2014 - GlobeNewswire
Elite Pharmaceuticals Showing Long Term Promise, Analyst Report by BrokerBank Securities, Inc. 7:30 a.m. May 5, 2014 - PR Newswire - PRF
FDA Approves Clinical Trial of BrainStorm Cell Therapeutics' ALS Treatment 10:06 a.m. April 29, 2014 - ACCESSWIRE
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology 7:43 a.m. April 22, 2014 - GlobeNewswire
Limitless Venture Group Settles $163,391 Note with Beaufort Capital Partners 10:08 a.m. April 16, 2014 - ACCESSWIRE
Limitless Venture Group Settles $163,391 Note with Beaufort Capital Partners 10:03 a.m. April 16, 2014 - ACCESSWIRE
Elite Pharmaceuticals to Receive up to 40 Million from Lincoln Park Capital Fund 10:02 a.m. April 15, 2014 - ACCESSWIRE
Elite Pharmaceuticals Appoints Barbara Ellison as Vice President of Quality Operations and Regulatory Affairs 12:16 p.m. March 27, 2014 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Globant Unleashes MuleSoft AI Pod for Faster Integration

Updated Category News Views 1

Unlocking the AI Puzzle: Webinar Speed Dials You ever swim through a mash-up of tech lingo that makes you feel like you're trudging through waist-high molasses? Well, Saddle up because that's exactly where Globant's new MuleSoft AI Pod is heading. Through Glob.AI, they're going all in on turning what used to take months into mere weeks—finally, right? In the business of...

Continue Reading
Syra Health Joins CMS ACCESS Model for Scalable Growth

Updated Category News Views 4

Syra Health Secures Spot in CMS ACCESS Model Every once in a while, a company gets a nod that could redefine its trajectory, and today it’s Syra Health’s turn at bat. Teaming up with HealthSync, they’ve clinched a position in the coveted CMS ACCESS model—a move not just about snagging headlines but potentially securing a golden ticket to a robust revenue stream...

Continue Reading
Médunik Canada Boosts Dravet Syndrome Support with Biocodex

Updated Category News Views 2

Breaking Down the Exclusive Médunik-Biocodex Partnership Listen, when a company like Médunik Canada, firmly rooted in Blainville, QC, throws its weight behind a rare disease drug like Diacomit®, folks in the industry take notice. Their recent handshake with Biocodex isn't just small talk; it opens doors to change how Dravet syndrome is managed across Canada. This new...

Continue Reading
Ohio's Visionary Leadership Honored with Prestigious Award

Updated Category News Views 4

Award for Exceptional Vision Care Leadership Ain't every day you see a politician scooping up awards for making a real difference in folks' lives. Yet here we are, tipping our hats to Ohio's Governor Mike DeWine, who's just been dubbed the honcho with the golden eye for children's vision care in the 12th annual Bonnie Strickland Champion for Children's Vision Award. Hats...

Continue Reading
Hamamatsu & AIxMed to Automate Cytology Workflows

Updated Category News Views 2

Why This Collaboration Matters Here comes an interesting tidbit from the world of cytology: Hamamatsu and AIxMed are banding together to tackle workflow inefficiencies. Picture this—two powerhouses coming together to create a tool that might just relieve lab technicians from the tedious task of manually checking cytology slides. In a world where efficiency is king, this...

Continue Reading
Doug Larson Takes Helm at Integra Pool Covers

Updated Category News Views 2

A Seasoned Pro Joins Integra Pool Covers Change is afoot over at Explore Industries. They just tapped Doug Larson to be the General Manager for their Integra Pool Covers division. Now, I've seen plenty of hiring announcements in my day, but this has got an interesting ring to it. With Doug on this ship, it's like bringing a wolf back to the wild. Larson's no stranger to...

Continue Reading
Nonprofit Option Rises for Specialty Physicians

Updated Category News Views 2

Reimaging Choices for Specialty Physicians In the whirlwind of healthcare, specialty physicians often find themselves between a rock and a hard place. The traditional paths are either hug a major health system or auction off to private equity, each option chaining them to systems more interested in the balance sheet than in patient care. But now, a third door opens. One...

Continue Reading
APX Bridges Crypto & Traditional Finance With New Credit Line

Updated Category News Views 0

The Future of Financial Bridging Now here's a scenario that might perk your ears up if you've ever toyed with digital assets: APX Lending is stepping up its game, bringing a regulated five-year revolving line of credit backed by Bitcoin and Ethereum to the world stage. It's like blending your grandma's tried-and-true savings approach with the whiz-bang allure of crypto. A...

Continue Reading
Jim Morey Joins Pickleman's to Drive Expansion

Updated Category News Views 3

Jim Morey: Catalyst for Pickleman's Ambitious Dreams You ever heard of a sandwich joint ready to take on the big leagues? Because that's just what Pickleman's Gourmet Café is banking on with their latest move—tapping none other than Jim Morey for their executive advisory board. And let me tell ya, this ain't some run-of-the-mill hire. We're talking about a guy who's...

Continue Reading
Photronics Investors Must Act by Sept. 4, 2026 Deadline

Updated Category News Views 1

Action Time for Photronics Investors There's nothing like a looming deadline to get the adrenaline pumping, especially when you're staring down the barrel of a federal securities class action. Photronics, Inc. (NASDAQ: PLAB) has found itself tangled in legal webs, with the clock ticking down to September 4, 2026. That’s the deadline for investors to move on being the...

Continue Reading

Top 5 Most Recently Viewed Articles

Protecting Young Athletes: Superspecs Enhances Eye Safety

Updated Category News Views 157

Empowering Youth Athletes with Eye Safety Initiatives Superspecs leads the charge in providing essential protective eyewear to ensure the safety of student-athletes as sports and recreation-related eye injuries remain a significant concern. As the only statewide initiative dedicated to safeguarding the vision of children up to the age of 18, Superspecs is actively...

Continue Reading
Tilray's Strategic Moves in the Cannabis Space: An In-Depth Look

Updated Category News Views 110

Understanding Tilray's Position in the Cannabis Market Tilray Brands (NASDAQ: TLRY) has emerged as a significant player in the cannabis sector, attracting attention from investors and analysts alike. Despite presenting a solid balance sheet and an array of international assets, its current investment standing remains cautious. Analysts have issued a 'Neutral' rating,...

Continue Reading
Citrine Power LLC Breaks Ground on Solar Project in New York

Updated Category News Views 206

Construction Begins on Solar Array by Citrine Power LLC Exciting news is on the horizon as Citrine Power LLC has officially kicked off the construction of a 3.6-MWac ground-mounted solar array. This marks a significant step forward in the pursuit of renewable energy solutions, contributing to a more sustainable future. Partnerships Fueling Development The Constable Solar...

Continue Reading
Predictive Oncology Partners with Renovaro for Improved Cancer Solutions

Updated Category News Views 171

Predictive Oncology and Renovaro's Strategic Partnership Predictive Oncology Inc. (NASDAQ: POAI), a prominent name in the field of artificial intelligence-driven drug discovery, is embarking on an exciting new chapter with its strategic partner Renovaro Biosciences, Inc. (NASDAQ: RENB). The companies have made headlines by finalizing a definitive merger agreement that...

Continue Reading
Analysts Adjust Expectations for Adobe Ahead of Earnings Report

Updated Category News Views 181

Analysts Adjust Expectations for Adobe Ahead of Earnings Report Adobe Inc. (NASDAQ: ADBE) is poised to announce its quarterly earnings figures, and the atmosphere is charged with anticipation. Analysts are forecasting a significant increase in Adobe's earnings to $5.39 per share, compared to $4.81 per share from the same period last year. This reflects an optimistic...

Continue Reading